Eden Research (LON:EDEN) Stock Price Down 13.2% – What’s Next?

Eden Research plc (LON:EDEN) fell 13.2% during mid-day trading on Monday . The company traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). 1,775,147 shares were traded during trading, an increase of 133% from the average session volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Stock Up 3.5 %

The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80. The firm has a market cap of £14.35 million, a PE ratio of -9.42 and a beta of 0.92. The firm’s 50-day moving average price is GBX 3.36 and its two-hundred day moving average price is GBX 3.71.

Insider Activity at Eden Research

In related news, insider Lykele van der Broek acquired 256,000 shares of the company’s stock in a transaction dated Thursday, February 6th. The stock was bought at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($13,238.53). Also, insider Alexander John Abrey acquired 167,947 shares of Eden Research stock in a transaction dated Tuesday, March 4th. The stock was purchased at an average cost of GBX 3 ($0.04) per share, for a total transaction of £5,038.41 ($6,513.78). Insiders have bought a total of 1,391,473 shares of company stock worth $103,604,725 in the last three months. Insiders own 14.02% of the company’s stock.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.